CA
LYRA

CoreCap Advisors’s LYRA THERAPEUTICS INC LYRA Stock Holding History

CoreCap Advisors’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$393 Buy
+3
New +$594 ﹤0.01% 2201
2022
Q3 		– Sell
-3
Closed -$1K – 1420
2022
Q2 		$1K Buy
+3
New +$817 ﹤0.01% 2014
2022
Q1 		– Sell
-3
Closed -$1K – 1419
2021
Q4 		$1K Buy
+3
New +$964 ﹤0.01% 2177

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CoreCap Advisors's LYRA Position: Q4 2022 in Review

CoreCap Advisors opened a new position in LYRA THERAPEUTICS INC (LYRA) in Q4 2022: 3 shares worth $393. The stake represents ﹤0.01% of the portfolio and ranks #2201 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in LYRA as recently as Q2 2022.

CoreCap Advisors first reported a position in LYRA in Q4 2021 and has held it in 3 quarters since. The position peaked at $1K in Q2 2022. 35 funds tracked by Wall St. Rank hold LYRA as of Q4 2022.

  • CoreCap Advisors held 3 shares of LYRA THERAPEUTICS INC worth $393 as of Q4 2022.
  • LYRA THERAPEUTICS INC was a new CoreCap Advisors position in Q4 2022.
  • LYRA THERAPEUTICS INC made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2201 holding.
  • CoreCap Advisors first reported a position in LYRA THERAPEUTICS INC in Q4 2021 and has held it in 3 quarters since.
  • CoreCap Advisors's LYRA THERAPEUTICS INC position peaked at $1K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.